The shares of this main photo voltaic inventory surged over 4 p.c after the corporate introduced that it had bagged an order price Rs 346 crore. On this article, we are going to dive deeper into the small print of the order.
With a market capitalization of Rs 10,868 crores, the shares of Waaree Renewables Applied sciences Ltd are presently buying and selling at Rs 1,043 per share, down by 58.60 p.c from its 52-week excessive of Rs 2,512.65 per share. Over the past one month, the inventory has delivered a return of 4.65 p.c.
Waaree Renewable Applied sciences Ltd has obtained a Letter of Award from Purvah Inexperienced Energy Pvt. Ltd., a subsidiary of CESC Ltd., for the implementation of a large-scale solar energy challenge in Bikaner, Rajasthan.
The challenge entails establishing a 300 MW AC / 435 MW DC ground-mounted solar energy producing station and covers your entire EPC scope, together with design, growth, provide, set up, testing, and commissioning, for Rs. 346.33 crore and the work is scheduled to be accomplished in the course of the FY 2025-26.
Monetary Highlights
The corporate reported a income of Rs 1,598 crores in FY25, up by 82.42 p.c from its FY24 income of Rs 876 crores. Coming to its profitability, it reported a internet revenue development of 54.72 p.c to Rs 229 crores in FY25 from Rs 148 crores in FY24.
The inventory has delivered an ROE and ROCE of 64.95 p.c and 84.91 p.c respectively, and is presently buying and selling at a P/E of 46.62x as in comparison with its trade common of 37.99x.
Waaree Renewable Applied sciences Restricted is an EPC firm within the renewable vitality sector. The Firm offers photo voltaic challenge growth, financing, building, and operation experience. Waaree Renewable Applied sciences operates rooftop, floating, and ground-mounted clear vitality techniques below each capex and RESCO fashions.
Written by Satyajeet Mukherjee
Disclaimer
The views and funding suggestions expressed by funding specialists/broking homes/ranking businesses on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a threat of monetary losses. Traders should subsequently train due warning whereas investing or buying and selling in shares. Dailyraven Applied sciences or the writer should not chargeable for any losses brought about because of the choice based mostly on this text. Please seek the advice of your funding advisor earlier than investing.
